The Recall Desk
HighFDA (Devices)·Z-0783-2024·Announced 2024-01-31

EliA GBM Diagnostic Wells Recalled for False Positive Results

Phadia Ab recalls 124,928 EliA GBM Wells diagnostic kits distributed nationwide due to complaints of false positive results. The wells produced unexpected positive signals in samples tested without antigen.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II recall of a diagnostic medical device without reported illnesses or injuries. The false positive results pose a risk of diagnostic inaccuracy and potential patient harm, meeting the criterion for a High severity rating.

Plain-English summary

Phadia Ab is recalling EliA GBM Wells (Material Number 14551401), which are components of Phadia 250, 2500, and 5000 in vitro diagnostic analyzers. Approximately 124,928 kits are affected and were distributed throughout the United States.

The recall was initiated following complaints that specific samples produced false positive results in EliA GBM testing. Investigation revealed that these wells exhibited unexpected coating-solution reactivity, generating a positive signal when samples without antigen were tested. This indicates the wells are producing false positive diagnostic results.

Affected customers should contact Phadia Ab for return or replacement instructions.

The recalled product

Product
EliA GBM Wells, Material Number 14551401, for Phadia 250, 2500, and 5000. In vitro diagnostic
Manufacturer
Phadia Ab
Hazard
  • false-positive-results

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UDI-DI: 07333066010670
  • All Lots.

Distribution

Distributed nationwide across the United States.